These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25994293)

  • 1. Bioeconomic analysis of child-targeted subsidies for artemisinin combination therapies: a cost-effectiveness analysis.
    Klein EY; Smith DL; Cohen JM; Laxminarayan R
    J R Soc Interface; 2015 Jun; 12(107):. PubMed ID: 25994293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the Affordable Medicines Facility--malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey data.
    Tougher S; ; Ye Y; Amuasi JH; Kourgueni IA; Thomson R; Goodman C; Mann AG; Ren R; Willey BA; Adegoke CA; Amin A; Ansong D; Bruxvoort K; Diallo DA; Diap G; Festo C; Johanes B; Juma E; Kalolella A; Malam O; Mberu B; Ndiaye S; Nguah SB; Seydou M; Taylor M; Rueda ST; Wamukoya M; Arnold F; Hanson K
    Lancet; 2012 Dec; 380(9857):1916-26. PubMed ID: 23122217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What happened to anti-malarial markets after the Affordable Medicines Facility-malaria pilot? Trends in ACT availability, price and market share from five African countries under continuation of the private sector co-payment mechanism.
    ; Tougher S; Hanson K; Goodman C
    Malar J; 2017 Apr; 16(1):173. PubMed ID: 28441956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in availability and prices of subsidized ACT over the first year of the AMFm: evidence from remote regions of Tanzania.
    Yadav P; Cohen JL; Alphs S; Arkedis J; Larson PS; Massaga J; Sabot O
    Malar J; 2012 Aug; 11():299. PubMed ID: 22929587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Socially-marketed rapid diagnostic tests and ACT in the private sector: ten years of experience in Cambodia.
    Yeung S; Patouillard E; Allen H; Socheat D
    Malar J; 2011 Aug; 10():243. PubMed ID: 21851625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The quest for universal access to effective malaria treatment: how can the AMFm contribute?
    Matowe L; Adeyi O
    Malar J; 2010 Oct; 9():274. PubMed ID: 20932286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into the Affordable Medicines Facility-malaria in Ghana: the role of caregivers and licensed chemical sellers in four regions.
    Adjei AA; Winch P; Laar A; Sullivan DJ; Sakyi KS; Stephens JK; Adjei GO; Boateng IA; Aubyn VN; Kubio C; Tuakli J; Vanotoo L; Bortei BB; Amo-Addae M; Sorvor F; Coleman N; Dalglish S; Owusu R; Gebreyesus T; Essuman E; Greene R; Ankomah E; Houston K; Bart-Plange C; Salamat S; Addison EA; Quakyi IA
    Malar J; 2016 May; 15(1):263. PubMed ID: 27160685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Affordable Medicines Facility-malaria--a success in peril.
    Talisuna AO; Adibaku S; Amojah CN; Amofah GK; Aubyn V; Dodoo A; Juma E; Jackou DH; Mkude S; Okui AP; Ramarosandratana B; Shija SJ
    Malar J; 2012 Nov; 11():370. PubMed ID: 23137141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analysis of malaria rapid diagnostic test incentive schemes for informal private healthcare providers in Myanmar.
    Chen IT; Aung T; Thant HN; Sudhinaraset M; Kahn JG
    Malar J; 2015 Feb; 14():55. PubMed ID: 25653121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards subsidized malaria rapid diagnostic tests. Lessons learned from programmes to subsidise artemisinin-based combination therapies in the private sector: a review.
    Lussiana C
    Health Policy Plan; 2016 Sep; 31(7):928-39. PubMed ID: 25862732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative costs and effectiveness of treating uncomplicated malaria in two rural districts in Zambia: implications for nationwide scale-up of home-based management.
    Chanda P; Hamainza B; Moonga HB; Chalwe V; Banda P; Pagnoni F
    Malar J; 2011 Jun; 10():159. PubMed ID: 21651828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost of uncomplicated childhood fevers to Kenyan households: implications for reaching international access targets.
    Larson BA; Amin AA; Noor AM; Zurovac D; Snow RW
    BMC Public Health; 2006 Dec; 6():314. PubMed ID: 17196105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving access to malaria medicine through private-sector subsidies in seven African countries.
    Tougher S; Mann AG; ; Ye Y; Kourgueni IA; Thomson R; Amuasi JH; Ren R; Willey BA; Ansong D; Bruxvoort K; Diap G; Festo C; Johanes B; Kalolella A; Mallam O; Mberu B; Ndiaye S; Nguah SB; Seydou M; Taylor M; Wamukoya M; Arnold F; Hanson K; Goodman C
    Health Aff (Millwood); 2014 Sep; 33(9):1576-85. PubMed ID: 25201662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do price subsidies on artemisinin combination therapy for malaria increase household use? Evidence from a repeated cross-sectional study in remote regions of Tanzania.
    Cohen JL; Yadav P; Moucheraud C; Alphs S; Larson PS; Arkedis J; Massaga J; Sabot O
    PLoS One; 2013; 8(7):e70713. PubMed ID: 23923018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of introducing subsidized combination treatment with artemether-lumefantrine on sales of anti-malarial monotherapies: a survey of private sector pharmacies in Huambo, Angola.
    Lussiana C; Floridia M; Martinho do Rosário J; Fortes F; Allan R
    Trans R Soc Trop Med Hyg; 2016 Dec; 110(10):588-596. PubMed ID: 27856948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy!
    Mutabingwa TK
    Acta Trop; 2005 Sep; 95(3):305-15. PubMed ID: 16098946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addressing child health inequity through case management of under-five malaria in Nigeria: an extended cost-effectiveness analysis.
    Dasgupta RR; Mao W; Ogbuoji O
    Malar J; 2022 Mar; 21(1):81. PubMed ID: 35264153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Affordable Medicines Facility-malaria (AMFm): are remote areas benefiting from the intervention?
    Ye Y; Arnold F; Noor A; Wamukoya M; Amuasi J; Blay S; Mberu B; Ren R; Kyobutungi C; Wekesah F; Gatakaa H; Toda M; Njogu J; Evance I; O'Connell K; Shewchuk T; Thougher S; Mann A; Willey B; Goodman C; Hanson K
    Malar J; 2015 Oct; 14():398. PubMed ID: 26452625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Willingness and ability to pay for artemisinin-based combination therapy in rural Tanzania.
    Saulo EC; Forsberg BC; Premji Z; Montgomery SM; Björkman A
    Malar J; 2008 Oct; 7():227. PubMed ID: 18976453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Communicating the AMFm message: exploring the effect of communication and training interventions on private for-profit provider awareness and knowledge related to a multi-country anti-malarial subsidy intervention.
    Willey BA; Tougher S; Ye Y; ; Mann AG; Thomson R; Kourgueni IA; Amuasi JH; Ren R; Wamukoya M; Rueda ST; Taylor M; Seydou M; Nguah SB; Ndiaye S; Mberu B; Malam O; Kalolella A; Juma E; Johanes B; Festo C; Diap G; Diallo D; Bruxvoort K; Ansong D; Amin A; Adegoke CA; Hanson K; Arnold F; Goodman C
    Malar J; 2014 Feb; 13():46. PubMed ID: 24495691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.